Robin Everts graduated with an MSc. in Animal Sciences from Wageningen Agricultural University in 1995 and received a PhD from the Department of Veterinary Medicine at Universiteit Utrecht in 2000. From 2000 to 2007, Robin conducted research in embryo/fetal functional genomics at the University of Illinois at Urbana-Champaign. Robin held various positions at Sequenom Biosciences from 2007 to 2014, focusing on Pharmacogenetics assay development, and then joined Agena Bioscience in 2014, where they served as Senior Manager and led the global Pharmacogenetics & Clinical Genetics team until 2023. Currently, Robin is the Head of Research & Development at Etalon Dx, where they lead bioinformatics and research efforts. Robin has authored 48 peer-reviewed papers.
This person is not in any teams
This person is not in any offices